Obesity Surgery

, Volume 29, Issue 4, pp 1174–1184 | Cite as

Comparison of Diabetes Remission and Micronutrient Deficiency in a Mildly Obese Diabetic Rat Model Undergoing SADI-S Versus RYGB

  • Tingfeng Wang
  • Yunlong Shen
  • Zhengdong Qiao
  • Yueqian Wang
  • Peng ZhangEmail author
  • Bo YuEmail author
Original Contribution



Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) has launched a huge challenge to classic Roux-en-Y gastric bypass (RYGB). Our objective was to compare diabetes remission and micronutrient deficiency in a mildly obese diabetic rat model undergoing SADI-S versus RYGB.


Thirty adult male mildly obese diabetic rats were randomly assigned to sham (S), SADI-S, and RYGB groups. Body weight, food intake, fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), plasma insulin, GLP-1, and ghrelin levels were measured at indicated time points. Meanwhile, insulin sensitivity and pancreatic β cell function were assessed during OGTT. Finally, plasma micronutrient evaluation and islet β cell mass analysis were performed after all animals were sacrificed.


As compared to sham, the SADI-S and RYGB groups achieved almost equivalent efficacy in caloric restriction and FPG control without excessive weight loss. During OGTT, the SADI-S and RYGB groups also provided comparable effects on glycemic excursion, insulin sensitivity, and β cell function; however, only rats in the RYGB group showed significant changes in gut hormones, whereas the three groups were found to exhibit no significant difference in β cell mass. In addition, only vitamin E in the RYGB group was deficient as compared with the SADI-S and S groups.


In mildly obese diabetic rat, SADI-S and RYGB procedures have comparable efficacy in diabetes remission and risk of micronutrient deficiency. These data show that each of the surgery accomplishes diabetes improvements through both overlapping and distinct mechanisms requiring further investigation.


Roux-en-Y gastric bypass Single-anastomosis duodeno-ileal bypass Diabetes remission Micronutrient 



The authors would like to thank Dr. Tao Yang for his excellent language editing support and valuable suggestions for manuscript revision. And thanks are also due to Ting Cao, Wen Wu, and Xiong Zhang for assistance with the experiments. This study was supported by the Science and Technology Development Fund of Shanghai Pudong New Area (Grant No. PKJ2015-Y35).

Compliance with Ethical Standards

The study protocol was reviewed and approved by the Institutional Animal Care and Utilization Committee (IACUC) of Fudan University Pudong Medical Center.

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

The research followed all applicable institutional and/or national guidelines for the care and use of animals, as well as was performed according to the recommendations of the Guide for the Care and Use of Laboratory Animals of the Ministry of Health, China.


  1. 1.
    Ma RC, Lin X, Jia W. Causes of type 2 diabetes in China. Lancet Diabetes Endocrinol. 2014;2(12):980–91.Google Scholar
  2. 2.
    Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090–101.Google Scholar
  3. 3.
    Zhang L, Qiao Q, Tuomilehto J, et al. Blood lipid levels in relation to glucose status in seven populations of Asian origin without a prior history of diabetes: the DECODA study. Diabetes Metab Res Rev. 2009;25(6):549–57.Google Scholar
  4. 4.
    Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Surg Obes Relat Dis. 2016;12(6):1144–62.Google Scholar
  5. 5.
    Sánchez-Pernaute A, Rubio Herrera MA, Pérez-Aguirre E, et al. Proximal duodenal-ileal end-to-side bypass with sleeve gastrectomy: proposed technique. Obes Surg. 2007;17(12):1614–8.Google Scholar
  6. 6.
    Brown WA, Ooi G, Higa K, et al. Single anastomosis duodenal-ileal bypass with sleeve gastrectomy/one anastomosis duodenal switch (SADI-S/OADS) IFSO position statement. Obes Surg. 2018;28:1207–16.Google Scholar
  7. 7.
    Zaveri H, Surve A, Cottam D, et al. Mid-term 4-year outcomes with single anastomosis duodenal-ileal bypass with sleeve gastrectomy surgery at a single US center. Obes Surg. 2018.
  8. 8.
    Mitzman B, Cottam D, Goriparthi R, et al. Stomach intestinal pylorus sparing (SIPS) surgery for morbid obesity: retrospective analyses of our preliminary experience. Obes Surg. 2016;26(9):2098–2104.9.Google Scholar
  9. 9.
    Surve A, Cottam D, Sanchez-Pernaute A, et al. The incidence of complications associated with loop duodeno-ileostomy after single-anastomosis duodenal switch procedures among 1328 patients: a multicenter experience. Surg Obes Relat Dis. 2018;14(5):594–601.Google Scholar
  10. 10.
    Cottam A, Cottam D, Zaveri H, et al. An analysis of mid-term complications, weight loss, and type 2 diabetes resolution of stomach intestinal pylorus-sparing surgery (SIPS) versus Roux-En-Y gastric bypass (RYGB) with three-year follow-up. Obes Surg. 2018;28:2894–902.Google Scholar
  11. 11.
    Hu C, Zhang G, Sun D, et al. Duodenal-jejunal bypass improves glucose metabolism and adipokine expression independently of weight loss in a diabetic rat model. Obes Surg. 2013;23(9):1436–44.Google Scholar
  12. 12.
    Wang T, Zhang P, Zhang X, et al. Duodenal-jejunal bypass attenuates progressive failure of pancreatic islets in streptozotocin-induced diabetic rats. Surg Obes Relat Dis. 2017;13(2):250–60.Google Scholar
  13. 13.
    Xu B, Yan X, Shao Y, et al. A comparative study of the effect of gastric bypass, sleeve gastrectomy, and duodenal–jejunal bypass on type-2 diabetes in non-obese rats. Obes Surg. 2015;25(10):1966–75.Google Scholar
  14. 14.
    Zhang X, Yu B, Yang D, et al. Gastric volume reduction is essential for the remission of type 2 diabetes mellitus after bariatric surgery in nonobese rats. Surg Obes Relat Dis. 2016;12(8):1569–76.Google Scholar
  15. 15.
    Kim J. American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. American Society for Metabolic and Bariatric Surgery statement on single-anastomosis duodenal switch. Surg Obes Relat Dis. 2016;12(5):944–5.Google Scholar
  16. 16.
    Di J, Zhang H, Yu H, et al. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m2. Surg Obes Relat Dis. 2016;12(7):1357–63.Google Scholar
  17. 17.
    Liang H, Guan W, Yang Y, et al. Roux-en-Y gastric bypass for Chinese type 2 diabetes mellitus patients with a BMI < 28 kg/m(2): a multi-institutional study. J Biomed Res. 2015;29(2):112–7.Google Scholar
  18. 18.
    Zhao L, Li W, Su Z, et al. Preoperative fasting C-peptide predicts type 2 diabetes mellitus remission in low-BMI Chinese patients after Roux-en-Y gastric bypass. J Gastrointest Surg. 2018;22:1672–8.Google Scholar
  19. 19.
    da Cruz SP, Matos A, Pereira S, et al. Roux-en-Y gastric bypass aggravates vitamin A deficiency in the Mother-Child Group. Obes Surg. 2018;28(1):114–21.Google Scholar
  20. 20.
    Kornerup LS, Hvas CL, Abild CB, Richelsen B, Nexo E. Early changes in vitamin B12 uptake and biomarker status following Roux-en-Y gastric bypass and sleeve gastrectomy. Clin Nutr. 2018;S0261–5614(18):30070-0.
  21. 21.
    Chakhtoura M, Rahme M, El-Hajj Fuleihan G, et al. Metabolism in bariatric surgery. Endocrinol Metab Clin N Am. 2017;46(4):947–82.Google Scholar
  22. 22.
    Mahawar KK, Bhasker AG, Bindal V, et al. Zinc deficiency after gastric bypass for morbid obesity: a systematic review. Obes Surg. 2017;27(2):522–9.Google Scholar
  23. 23.
    van den Broek M, de Heide LJM, Emous M, et al. Satiety and gastrointestinal hormones during a mixed meal tolerance test after gastric bypass surgery: association with plasma amino acid concentrations. Surg Obes Relat Dis. 2018;14(8):1106–17.Google Scholar
  24. 24.
    de Hollanda A, Casals G, Delgado S, et al. Gastrointestinal hormones and weight loss maintenance following Roux-en-Y gastric bypass. J Clin Endocrinol Metab. 2015;100(12):4677–84.Google Scholar
  25. 25.
    de Hollanda A, Jiménez A, Corcelles R, et al. Gastrointestinal hormones and weight loss response after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2014;10(5):814–9.Google Scholar
  26. 26.
    Jørgensen NB, Dirksen C, Bojsen-Møller KN, et al. Exaggerated glucagon-like peptide 1 response is important for improved beta-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes. Diabetes. 2013;62(9):3044–52.Google Scholar
  27. 27.
    Bojsen-Møller KN. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Dan Med J. 2015;62(4):B5057.Google Scholar
  28. 28.
    Mingrone G, Castagneto M. Bariatric surgery: unstressing or boosting the beta-cell? Diabetes Obes Metab. 2009;11(Suppl. 4):130–42.Google Scholar
  29. 29.
    Fujitani Y. How does glucagon-like peptide 1 stimulate human beta-cell proliferation? A lesson from islet graft experiments. J Diabetes Investig. 2018;9:1255–7.Google Scholar
  30. 30.
    Dutia R, Brakoniecki K, Bunker P, et al. Limited recovery of beta-cell function after gastric bypass despite clinical diabetes remission. Diabetes. 2014;63(4):1214–23.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Center for Metabolic and Bariatric SurgeryShanghai Pudong Hospital, Fudan University Pudong Medical CenterShanghaiChina
  2. 2.Center for Medical Research and InnovationShanghai Pudong Hospital, Fudan University Pudong Medical CenterShanghaiChina

Personalised recommendations